Matches in SemOpenAlex for { <https://semopenalex.org/work/W4320717077> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W4320717077 endingPage "e13747" @default.
- W4320717077 startingPage "e13747" @default.
- W4320717077 abstract "Chronic kidney disease (CKD) is a global disease, and the number of people affected is increasing due to driving factors such as diabetes, obesity, and hypertension, as well as increased life expectancy. Many patients with CKD suffer anemia throughout the period of their disease.This research aimed to investigate the relation between resistance to the methoxy polyethylene glycol-epoetin beta (ME-β) and angiotensin-converting enzyme (ACE) gene polymorphism.Seventy Iraqi patients with CKD on hemodialysis treatment for at least six months and receiving a subcutaneous injection of ME-β were selected to enroll in this current study. In addition to these patients, the control group of 20 healthy subjects. Baseline samples (Three blood samples) were obtained and withdrawn from each participant, then 3 and 6 months following the starting sample. In addition, a unique blood sample was taken from each participant in the control group in the early morning hours following 8 h of fasting and before dialysis (for the patients' group).ACE polymorphism did not demonstrate a significant (p ˃ 0.05) relation with changing the dose of ME-β. Furthermore, there was a negative relationship between ME-β dose and hemoglobin (Hb) in CKD patients. Comparing ACE polymorphism between good and hypo-response groups shows no significant effect (p ˃ 0.05) on ME-β therapy. Moreover, the erythropoietin resistance index (ERI) was significantly (p < 0.001) lower in good responders to ME-β therapy compared to the hypo-response group. Finally, comparing the ERI of the patient, the good response group to the hypo-response group showed no significant association (p ˃ 0.05) with ACE gene polymorphism in response to ME-β therapy.No relation was determined between the polymorphism ACE gene and the resistance to the ME-β administration in CKD Iraqi patients." @default.
- W4320717077 created "2023-02-15" @default.
- W4320717077 creator A5011186082 @default.
- W4320717077 creator A5021867693 @default.
- W4320717077 creator A5063509353 @default.
- W4320717077 date "2023-02-01" @default.
- W4320717077 modified "2023-10-16" @default.
- W4320717077 title "The resistance to methoxy polyethylene glycol-epoetin beta in anemic patients of end-stage renal disease" @default.
- W4320717077 cites W182592261 @default.
- W4320717077 cites W1975876644 @default.
- W4320717077 cites W2005495277 @default.
- W4320717077 cites W2010479956 @default.
- W4320717077 cites W2024841768 @default.
- W4320717077 cites W2030349763 @default.
- W4320717077 cites W2035264210 @default.
- W4320717077 cites W2072506649 @default.
- W4320717077 cites W2097532633 @default.
- W4320717077 cites W2103770548 @default.
- W4320717077 cites W2113760558 @default.
- W4320717077 cites W2132155262 @default.
- W4320717077 cites W2152489630 @default.
- W4320717077 cites W2186441364 @default.
- W4320717077 cites W2416386816 @default.
- W4320717077 cites W2577173078 @default.
- W4320717077 cites W2938968314 @default.
- W4320717077 cites W2941651537 @default.
- W4320717077 cites W2955707971 @default.
- W4320717077 cites W2960344056 @default.
- W4320717077 cites W2986921917 @default.
- W4320717077 cites W3022785442 @default.
- W4320717077 cites W3024832519 @default.
- W4320717077 cites W3092275232 @default.
- W4320717077 cites W4245479300 @default.
- W4320717077 cites W4249150518 @default.
- W4320717077 doi "https://doi.org/10.1016/j.heliyon.2023.e13747" @default.
- W4320717077 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36865462" @default.
- W4320717077 hasPublicationYear "2023" @default.
- W4320717077 type Work @default.
- W4320717077 citedByCount "0" @default.
- W4320717077 crossrefType "journal-article" @default.
- W4320717077 hasAuthorship W4320717077A5011186082 @default.
- W4320717077 hasAuthorship W4320717077A5021867693 @default.
- W4320717077 hasAuthorship W4320717077A5063509353 @default.
- W4320717077 hasBestOaLocation W43207170771 @default.
- W4320717077 hasConcept C126322002 @default.
- W4320717077 hasConcept C134018914 @default.
- W4320717077 hasConcept C2778063415 @default.
- W4320717077 hasConcept C2778248108 @default.
- W4320717077 hasConcept C2778534260 @default.
- W4320717077 hasConcept C2778653478 @default.
- W4320717077 hasConcept C2778917026 @default.
- W4320717077 hasConcept C2779978075 @default.
- W4320717077 hasConcept C3019040382 @default.
- W4320717077 hasConcept C555293320 @default.
- W4320717077 hasConcept C71924100 @default.
- W4320717077 hasConcept C90924648 @default.
- W4320717077 hasConceptScore W4320717077C126322002 @default.
- W4320717077 hasConceptScore W4320717077C134018914 @default.
- W4320717077 hasConceptScore W4320717077C2778063415 @default.
- W4320717077 hasConceptScore W4320717077C2778248108 @default.
- W4320717077 hasConceptScore W4320717077C2778534260 @default.
- W4320717077 hasConceptScore W4320717077C2778653478 @default.
- W4320717077 hasConceptScore W4320717077C2778917026 @default.
- W4320717077 hasConceptScore W4320717077C2779978075 @default.
- W4320717077 hasConceptScore W4320717077C3019040382 @default.
- W4320717077 hasConceptScore W4320717077C555293320 @default.
- W4320717077 hasConceptScore W4320717077C71924100 @default.
- W4320717077 hasConceptScore W4320717077C90924648 @default.
- W4320717077 hasIssue "2" @default.
- W4320717077 hasLocation W43207170771 @default.
- W4320717077 hasLocation W43207170772 @default.
- W4320717077 hasLocation W43207170773 @default.
- W4320717077 hasOpenAccess W4320717077 @default.
- W4320717077 hasPrimaryLocation W43207170771 @default.
- W4320717077 hasRelatedWork W1548762503 @default.
- W4320717077 hasRelatedWork W1981712819 @default.
- W4320717077 hasRelatedWork W2028422286 @default.
- W4320717077 hasRelatedWork W2350089469 @default.
- W4320717077 hasRelatedWork W2364659167 @default.
- W4320717077 hasRelatedWork W2412425337 @default.
- W4320717077 hasRelatedWork W2746183029 @default.
- W4320717077 hasRelatedWork W2805683016 @default.
- W4320717077 hasRelatedWork W2885191723 @default.
- W4320717077 hasRelatedWork W4377820566 @default.
- W4320717077 hasVolume "9" @default.
- W4320717077 isParatext "false" @default.
- W4320717077 isRetracted "false" @default.
- W4320717077 workType "article" @default.